Not available
Quote | Wave Life Sciences Ltd. (NASDAQ:WVE)
Last: | $6.175 |
---|---|
Change Percent: | -0.34% |
Open: | $5.86 |
Close: | $6.175 |
High: | $6.19 |
Low: | $5.86 |
Volume: | 1,270,439 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | Wave Life Sciences Ltd. (NASDAQ:WVE)
2024-07-17 15:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 13:34:14 ET Mizhuo picks Axsome Therapeutics ( AXSM ), Wave Life Sciences ( WVE ), Arcutis Biotherapeutics ( ARQT ), LivaNova ( LIVN ) and Humana ( HUM ) as July’s top picks.... Read the full article on Seeking Alpha For further details see:...
Message Board Posts | Wave Life Sciences Ltd. (NASDAQ:WVE)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $WVE 25% v5,8M c6.02 f86,9M H6.75 ML3.04 RL3.95 | znewcar1 | investorshangout | 12/15/2022 12:57:32 AM |
Big clinical news coming shortly | PRIVATE SHAREHOLDER | investorshub | 10/28/2022 8:35:11 PM |
Company reporting big news next week. Stay tuned! | PRIVATE SHAREHOLDER | investorshub | 10/28/2022 5:35:17 PM |
WVE stretched out this morning! | MiamiGent | investorshub | 10/20/2022 2:24:48 AM |
znewcar1: WVE 26% v798K c10.11 f34,6M H10.47 eod push | znewcar1 | investorshangout | 05/11/2020 8:42:25 PM |
News, Short Squeeze, Breakout and More Instantly...
Wave Life Sciences Ltd. Company Name:
WVE Stock Symbol:
NASDAQ Market:
Wave Life Sciences Ltd. Website:
2024-07-17 15:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Statistically significant, potent, and durable allele-selective silencing: 46% mean reduction in CSF mutant huntingtin (mHTT) protein compared to placebo, preservation of wild-type huntingtin (wtHTT) protein, and generally safe and well-tolerated profile achieved in 30 mg multidose cohort ...
Presentation at the Obesity & Weight Loss Drug Development Summit to review Real World Evidence for the GLP-1 class and the opportunity for Wave’s INHBE program as a best-in-class approach for obesity designed to induce fat burning and preserve muscle mass with once or twice-annual sub...